Combining Early Ischemic Change and Collateral Extent for Functional Outcomes After Endovascular Therapy: An Analysis From AcT Trial
Koji Tanaka,Chitapa Kaveeta,Umberto Pensato,Jianhai Zhang,Fouzi Bala,Ibrahim Alhabli,MacKenzie Horn,Ayoola Ademola,Mohammed Almekhlafi,Aravind Ganesh,Brian Buck,Aleksander Tkach,Luciana Catanese,Dar Dowlatshahi,Jai Shankar,Alexandre Y. Poppe,Michel Shamy,Wu Qiu,Richard H. Swartz,Michael D. Hill,Tolulope T. Sajobi,Bijoy K. Menon,Andrew M. Demchuk,Nishita Singh
DOI: https://doi.org/10.1161/strokeaha.123.046056
IF: 10.17
2024-05-26
Stroke
Abstract:Stroke, Ahead of Print. BACKGROUND:Early ischemic change and collateral extent are colinear with ischemic core volume (ICV). We investigated the relationship between a combined score using the Alberta Stroke Program Early Computed Tomography Score and multiphase computed tomography angiography (mCTA) collateral extent, named mCTA-ACE score, on functional outcomes in endovascular therapy–treated patients.METHODS:We performed a post hoc analysis of a subset of endovascular therapy–treated patients from the Alteplase Compared to Tenecteplase trial which was conducted between December 2019 and January 2022 at 22 centers across Canada. Ten-point mCTA collateral corresponding to M2 to M6 regions of the Alberta Stroke Program Early Computed Tomography Score grid was evaluated as 0 (poor), 1 (moderate), or 2 (normal) and additively combined with the 10-point Alberta Stroke Program Early Computed Tomography Score to produce a 20-point mCTA-ACE score. We investigated the association of mCTA-ACE score with modified Rankin Scale score ≤2 and return to prestroke level of function at 90 to 120 days using mixed-effects logistic regression. In the subset of patients who underwent baseline computed tomography perfusion imaging, we compared the mCTA-ACE score and ICV for outcome prediction.RESULTS:Among 1577 intention-to-treat population in the trial, 368 (23%; 179 men; median age, 73 years) were included, with Alberta Stroke Program Early Computed Tomography Score, mCTA collateral, and combination of both (mCTA-ACE score: median [interquartile range], 8 [7–10], 9 [8–10], and 17 [16–19], respectively). The probability of modified Rankin scale score ≤2 and return to prestroke level of function increased for each 1-point increase in mCTA-ACE score (odds ratio, 1.16 [95% CI, 1.06–1.28] and 1.22 [95% CI, 1.06–1.40], respectively). Among 173 patients in whom computed tomography perfusion data was assessable, the mCTA-ACE score was inversely correlated with ICV (ρ=−0.46;P<0.01). The mCTA-ACE score was comparable to ICV to predict a modified Rankin scale score ≤2 and return to prestroke level of function (C statistics 0.71 versus 0.69 and 0.68 versus 0.64, respectively).CONCLUSIONS:The mCTA-ACE score had a significant positive association with functional outcomes after endovascular therapy and had a similar predictive performance as ICV.
peripheral vascular disease,clinical neurology